Literature DB >> 19208677

Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration.

K Sayanagi1, S Sharma, P K Kaiser.   

Abstract

AIMS: To evaluate the photoreceptor layer status after antivascular endothelial growth factor (VEGF) therapy in choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD) using spectral-domain optical coherence tomography (SD-OCT).
DESIGN: Prospective, consecutive case series.
METHODS: Twenty-three eyes of 22 patients with CNV secondary to AMD with foveal thickness less than 250 microm after treatment with anti-VEGF therapy and no obvious leakage on time domain OCT, and eight healthy subjects as controls, were imaged with at least one of four different SD-OCT devices. The inner and outer segment (IS/OS) photoreceptor layers were graded, and correlated with various characteristics including visual acuity.
RESULTS: The IS/OS layer was detected in eight eyes (35%) of patients with AMD and all eyes (100%) of the healthy control subjects (p = 0.002). Eyes in patients with AMD with preserved IS/OS had a significantly better BCVA and mean change in BCVA, and were more likely not to have had previous laser treatment compared with eyes with absent IS/OS.
CONCLUSIONS: SD-OCT is a useful tool to visualise IS/OS status. IS/OS is often absent in patients who have received treatment with anti-VEGF therapy for CNV due to AMD. The IS/OS status after anti-VEFG therapy correlates with BCVA and mean change in vision.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19208677     DOI: 10.1136/bjo.2008.151977

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  Relationship between retinal morphological findings and visual function in age-related macular degeneration.

Authors:  Yumiko Akagi-Kurashige; Akitaka Tsujikawa; Akio Oishi; Sotaro Ooto; Kenji Yamashiro; Hiroshi Tamura; Isao Nakata; Naoko Ueda-Arakawa; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08       Impact factor: 3.117

2.  Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization.

Authors:  U Introini; G Casalino; G Querques; A T Gimeno; F Scotti; F Bandello
Journal:  Eye (Lond)       Date:  2012-04-27       Impact factor: 3.775

3.  Qualitative and quantitative OCT response of diffuse diabetic macular oedema to macular laser photocoagulation.

Authors:  R Vemala; S Koshy; S Sivaprasad
Journal:  Eye (Lond)       Date:  2011-04-15       Impact factor: 3.775

4.  Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration.

Authors:  Akio Oishi; Masataka Shimozono; Michiko Mandai; Masayuki Hata; Akihiro Nishida; Yasuo Kurimoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-12       Impact factor: 3.117

5.  High-resolution Fourier-domain optical coherence tomography of choroidal neovascular membranes associated with age-related macular degeneration.

Authors:  Susanna S Park; Steven N Truong; Robert J Zawadzki; Suhail Alam; Stacey S Choi; David G Telander; John S Werner; Lawrence S Morse
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-10       Impact factor: 4.799

6.  Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?

Authors:  Paolo Milani; Marco Pellegrini; Amedeo Massacesi; Stefania Moschini; Marco Setaccioli; Davide Soranna; Antonella Zambon; Ferdinando Bottoni; Fulvio Bergamini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-30       Impact factor: 3.117

7.  Association between photoreceptor integrity and visual outcome in diabetic macular edema.

Authors:  Hyun Jin Shin; Seung Hyen Lee; Hyewon Chung; Hyung Chan Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-27       Impact factor: 3.117

8.  Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Praveen J Patel; Yanling Ouyang; Fred K Chen; Felicia Ikeji; Alexander C Walsh; Adnan Tufail; Srinivas R Sadda
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-16       Impact factor: 4.799

9.  Predicting visual outcomes for macular disease using optical coherence tomography.

Authors:  Pearse A Keane; Srinivas R Sadda
Journal:  Saudi J Ophthalmol       Date:  2011-01-26

10.  CCR3 is a target for age-related macular degeneration diagnosis and therapy.

Authors:  Atsunobu Takeda; Judit Z Baffi; Mark E Kleinman; Won Gil Cho; Miho Nozaki; Kiyoshi Yamada; Hiroki Kaneko; Romulo J C Albuquerque; Sami Dridi; Kuniharu Saito; Brian J Raisler; Steven J Budd; Pete Geisen; Ariel Munitz; Balamurali K Ambati; Martha G Green; Tatsuro Ishibashi; John D Wright; Alison A Humbles; Craig J Gerard; Yuichiro Ogura; Yuzhen Pan; Justine R Smith; Salvatore Grisanti; M Elizabeth Hartnett; Marc E Rothenberg; Jayakrishna Ambati
Journal:  Nature       Date:  2009-06-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.